Virpax Pharmaceuticals

NasdaqCM:VRPX Stock Report

Mkt Cap: US$13.8m

Virpax Pharmaceuticals Future Growth

How is Virpax Pharmaceuticals forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


-21.9%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: VRPX is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: VRPX is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: VRPX is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: Insufficient data to determine if VRPX's revenue is forecast to grow faster than the US market.

High Growth Revenue: VRPX is forecast to have no revenue next year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if VRPX's Return on Equity is forecast to be high in 3 years time


Discover growth companies